Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.
作者信息
Ossenkoppele G J, Breems D A, Stuessi G, van Norden Y, Bargetzi M, Biemond B J, A von dem Borne P, Chalandon Y, Cloos J, Deeren D, Fehr M, Gjertsen B, Graux C, Huls G, Janssen J J J W, Jaspers A, Jongen-Lavrencic M, de Jongh E, Klein S K, van der Klift M, van Marwijk Kooy M, Maertens J, Michaux L, van der Poel M W M, van Rhenen A, Tick L, Valk P, Vekemans M C, van der Velden W J F M, de Weerdt O, Pabst T, Manz M, Löwenberg B
机构信息
Amsterdam University Medical Cente, location VUMC, Amsterdam, Netherlands.
Netwerk Antwerpen, Antwerp, Belgium.
出版信息
Leukemia. 2020 Oct;34(10):2820. doi: 10.1038/s41375-020-0994-7.
PMID:32733013
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
摘要
Zotero 插件